Applying the benefits of the AwM Study in the clinic

Cephalalgia

Volumn 28, Issue SUPPL. 2, 2008, Pages 42-49

  Dodick, D W ^a  

^a MAYO CLINIC   (United States)

Author keywords

Early treatment; Migraine; Triptan; Window of opportunity

Indexed keywords

ANALGESIC AGENT; ERGOTAMINE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE;

CONSULTATION; DIAGNOSTIC ACCURACY; DISABILITY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EARLY DIAGNOSIS; EARLY INTERVENTION; HUMAN; MIGRAINE; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; PROFESSIONAL KNOWLEDGE; REVIEW;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANALGESICS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MULTICENTER STUDIES AS TOPIC; PATIENT SATISFACTION; PATIENTS; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF ADMINISTRATION; SEROTONIN AGONISTS; TRYPTAMINES; VASOCONSTRICTOR AGENTS;

EID: 48249091372     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01690.x     Document Type: Review

References (21)

1. Edmeads J. Understanding the needs of migraine patients. Drugs 2006 66 (Suppl. 3 1 8.
2. Goadsby PJ. The AwM - 'Act when Mild' - study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia 2008 28 (Suppl. 2 36 41.
3. Silberstein SD, Bigal ME, Peterlin BE, Grosberg BB, Young WB, Pearlman SH et al. Practice parameter: evidence-based guidelines for the acute treatment of migraine headache. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (in press).
4. Kaniecki R. Headache assessment and management. JAMA 2003 289 : 1430 3.
5. Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J et al. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology 2003 61 : 375 82.
6. Cady RK, Borchert LD, Spalding W, Hart CC, Sheftell FD. Simple and efficient recognition of migraine with 3-question headache screen. Headache 2004 44 : 323 7.
7. Pascual J, Leira R, Láinez JM, Alberca R, Titus F, Morales F et al. Estudio español de calidad de vida la migraña (II). Patrón de consumo de fármacos y eficacia subjetiva. Neurologia 1999 14 : 204 9.
8. Ceballos Hernansanz MA, Sanchez RR, Cano Orgaz A, Lopez-Gil A. Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness. Clin Ther 2003 25 : 2053 69.
9. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache 2003 43 : 19 26.
10. Pascual J. Almotriptan in triptan-naïve patients: new evidence of benefits. Cephalalgia 2008 28 (Suppl. 2 14 20.
11. Dodick DW, Sandrini G, Williams P. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS Drugs 2007 21 : 73 82.
12. European Headache Foundation. EHF/WHA Rome Declaration on Migraine. Consensus Actions, June 2005. [WWW document]. URL http://www.ehf-org.org/pdf/ WHA_EHF_DeclarationRome.pdf (accessed 11 July 2007).
13. Foley KA, Cady R, Martin V, Adelman J, Diamond M, Bell CF et al. Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine. Headache 2005 45 : 538 45.
14. Gendolla A. Early treatment in migraine: how strong is the current evidence? Cephalalgia 2008 28 (Suppl. 2 28 35.
15. Ng-Mak DS, Cady R, Chen YT, Ma L, Bell CF, Hu XH. Can migraineurs accurately identify their headaches as 'migraine' at attack onset? Headache 2007 47 : 645 53.
16. Sculpher M, Millson D, Meddis D, Poole L. Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: the Disability in Strategies for Care (DISC) Study. Pharmacoeconomics 2002 20 : 91 100.
17. Lucas C. Strategies to improve migraine treatment results. Drugs 2006 66 (Suppl. 3 9 16.
18. Pryse-Phillips W, Aube M, Bailey P, Becker WJ, Bellavance A, Gawel M et al. A clinical study of migraine evolution. Headache 2006 46 : 1480 6.
19. Dodick DW, Kori S, Lipton R, McDonald S, Nelson A, Silberstein S. Opportunity for early intervention in a clinical setting. Abstract presented at the 13th congress of the International Headache Society, Stockholm, Sweden, 28 June-1 July 2007.
20. Nicholson RA, Smith TR, Banks JW. Insurance limitations and cost of triptans negatively influence triptan use, adherence and quality of life. Headache 2007 47 : 777.
21. Smith TR, Banks JW, Nicholson RA. Is a triptan the first medication you take? How order of use differentiates migraine sufferers' triptan adherence and quality of life. Headache 2007 47 : 755.